News

20 Sep 2021
New results from immunotherapy trials from the EORTC gynaecological and lung cancer groups presented at ESMO 2021

16 Sep 2021
View our webinar “Clinical Trials: the patient in academic studies” (September 15, 2021)

28 Aug 2021
News from the ESTRO 2021 congress: EORTC-ESTRO RADiation Infrastructure for Europe (E2-RADIatE) OligoCare trial assesses real-world patterns of practice of radical radiotherapy for oligometastatic disease

28 Aug 2021
News from the ESTRO 2021 congress: Denis Lacombe, awarded honorary membership of ESTRO, emphasises the importance of radiation oncology in multidisciplinary research

30 Jul 2021
Combined hormone/radiotherapy treatment improves event-free and disease-free survival in patients with localised intermediate risk prostate cancer; long-term results from EORTC Trial 22991

27 Jul 2021
EORTC 1634-Brain Tumour Group trial in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma (PersoMed-I) receives support from Gateway for Cancer Research℠

25 Jun 2021
European Health Stakeholder Group Statement on the UK data protection regime

21 Jun 2021
EORTC announces new governance with new Board of Directors and President-Elect

9 Jun 2021
EORTC in the spotlight at ASCO 2021

4 Jun 2021
EORTC selected abstracts at ASCO 2021

